Skip to Main Content

Paper Details

Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2.
Nat Commun
88
2022
-expressing extracellular vesicles, ACE2, ACE2 receptor, COVID-19, EVs, SARS, SARS-CoV, SARS-CoV-2, angiotensin-converting enzyme 2, cellular ACE2, circulating extracellular vesicles, coronavirus induced disease, evACE2, hACE2, host cells, human, human plasma, lung injury, mice, patients, recombinant human ACE2, rhACE2, severe acute respiratory syndrome coronavirus, viral spike protein RBD, wildtype strain
Author NameAffiliation
Chengsheng MaoNorthwestern University Feinberg School of Medicine
Chengsheng MaoNorthwestern University Feinberg School of Medicine
Chia-Feng TsaiPacific Northwest National Laboratory
Chia-Feng TsaiPacific Northwest National Laboratory
Yuzhi JiaNorthwestern University Feinberg School of Medicine
Yang ShenTEES-AgriLife Center for Bioinformatics and Genomic Systems Engineering, Texas A&M University, College Station
Yang ShenTEES-AgriLife Center for Bioinformatics and Genomic Systems Engineering, Texas A&M University, College Station
Tujin ShiPacific Northwest National Laboratory
Tujin ShiPacific Northwest National Laboratory
Yuan LuoNorthwestern University Feinberg School of Medicine
Yuan LuoNorthwestern University Feinberg School of Medicine
Huiping LiuNorthwestern University Feinberg School of Medicine
Huiping LiuRobert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Huiping LiuNorthwestern University Feinberg School of Medicine
  • 1 - 14

Datasets

Release 1.2